DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 3.02% to $2.57 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 3.56% to 22,204.43 and Dow Jones Industrial Average falling 1.90% to 45,479.60.
The stock's fall snapped a two-day winning streak.
Inovio Pharmaceuticals Inc. closed 55.92% below its 52-week high of $5.83, which the company reached on October 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.19% to $190.72, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 1.82% to $24.78.
Trading volume (1.0 M) remained 695,151 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 10, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 10, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.